Infections, inflammation, and the risk of coronary heart disease

Circulation

Volumn 101, Issue 3, 2000, Pages 252-257

  Roivainen, Merja ^a   Viik Kajander, Maarit ^a   Palosuo, Timo ^a   Toivanen, Petri ^b   Leinonen, Maija ^a   Saikku, Pekka ^a   Tenkanen, Leena ^c   Manninen, Vesa ^c   Hovi, Tapani ^a   Mänttäri, Matti ^c  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b WIHURI RESEARCH INSTITUTE   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Coronary disease; Infection; Inflammation; Proteins

Indexed keywords

BACTERIUM ANTIBODY; C REACTIVE PROTEIN; VIRUS ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; CARDIOVASCULAR RISK; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ASSOCIATION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MYOCARDITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT;

EID: 0034711676     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.3.252     Document Type: Article

References (47)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999; 340:115-126.
2. Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation. 1997;96:4095-4103.
3. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med. 1994;331: 417-424.
4. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW, for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med. 1995;332:635-641.
5. Haverkate F, Thompson SG, Pyke SDM, Gallimore JR, Pepys MB, for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet. 1997;349:462-466.
6. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation. 1998;98:731-733.
7. Koenig W, Sund M, Fröhlich M, Fischer H-G, Löwel H, Döring A, Hutchinson WL, Pepys MB. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Circulation. 1999;99:237-242.
8. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Mäkela PH, Huttunen JK, Valtonen V. Serologic evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 1988;2:983-985.
9. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997;350:430-436.
10. Mattila KJ, Valtonen VV, Nieminen MS, Asikainen S. Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke. Clin Infect Dis. 1998;26:719-734.
11. Nieto FJ. Infections and atherosclerosis: new clues from an old hypotheses? Am J Epidemiol. 1998;148:937-948.
12. Woodruff JF. Viral myocarditis: a review. Am J Pathol. 1980;101: 425-484.
13. Sohal RS, Burch GE, Chu KC, Leiderman E, Colcolough HL. Ultrastructural changes in cardiac capillaries of coxsackie virus b4-infected mice. Lab Invest. 1968;19:399-405.
14. Grist NR, Bell EJ. A six-year study of coxsackievirus B infections in heart disease. J Hyg (Camb). 1974;73:165-172.
15. Woods JD, Nimmo MJ, Mackay-Scollay EM. Acute transmural myocardial infarction associated with active coxsackie virus B infection. Am Heart J. 1975;89:283-287.
16. Nicholls AC, Thomas M. Coxsackie virus infection in acute myocardial infarction. Lancet. 1977;1:883-884.
17. Wood SF, Rogen AS, Bell EJ, Grist NR. Role of coxsackie B viruses in myocardial infarction. Br Heart J. 1978;40:523-525.
18. Griffiths PD, Hannington G, Booth JC. Coxsackie B virus infections and myocardial infarction. Lancet. 1980;1:1387-1389.
19. Nikoskelainen J, Kalliomäki JL, Lapinleimu K, Stenvik M, Halonen PE. Coxsackie B virus antibodies in myocardial infarction. Acta Med Scand. 1983;214:29-32.
20. Roivainen M, Alfthan G, Jousilahti P, Kimpimäki M, Hovi T, Tuomilehto J. Enterovirus infections as a possible risk factor for myocardial infarction. Circulation. 1998;98:2534-2537.
21. Melnick JL, Petrie BL, Dreesman GR, Burek J, McCollum CH, DeBakey ME. Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet. 1983;2:644-647.
22. Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, Epstein SE. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science. 1994;265:391-394.
23. Zhou YF, Leon MB, Waclawiw MA, Popma JJ, Yu ZX, Finkel T, Epstein SE. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med. 1996;335:624-630.
24. Benditt EP, Barret T, McDougall JK. Viruses in the etiology of atherosclerosis. Proc Natl Acad Sci U S A. 1983;80:6386-6389.
25. Gyorkey F, Melnick JL, Guinn GA, Gyorkey P, DeBakey ME. Herpes viridae in the endothelial and smooth muscle cells of the proximal aorta of atherosclerotic patients. Exp Mol Pathol. 1984;40:328-339.
26. Yamashiroya HM, Ghosh L, Yang R, Robertson AL. Herpesviridae in the coronary arteries and aorta of young trauma victims. Am J Pathol. 1988;130:71-79.
27. Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V, Mäenpää H, Mälkönen M, Mänttäri M, Norola S, Pasternack A, Pikkarainen J, Romo M, Sjöblom T, Nikkilä EA. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia: safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med. 1987;317:1237-1245.
28. Heinonen OP, Huttunen JK, Manninen V, Mänttäri M, Koskinen P, Tenkanen L, Frick MH. Helsinki Heart Study: coronary heart disease incidence during an extended follow-up. J Intern Med. 1994;235:41-49.
29. Hovi T, Roivainen M. Peptide antisera targeted to a conserved sequence in poliovirus capsid protein VP1 cross-react widely with members of the genus enterovirus. J Clin Microbiol. 1993;31:1083-1087.
30. Samuelsson A, Cello J, Skoog E, Glimåker M, Jeansson S, Forsgren M. Enterovirus IgG ELISA using synthetic peptides as antigens. Serodiagn Immunother Infect Dis. 1993;5:93-96.
31. Hyöty H, Hiltunen M, Knip M, Laakkonen M, Vähäsalo P, Karjalainen J, Koskela P, Roivainen M, Leinikki P, Hovi T, Åkerblom HK, the Childhood Diabetes in Finland (DiMe) Study Group. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Diabetes. 1995;44:652-657.
32. Ekman MR, Grayston JT, Visakorpi R, Kleemola M, Kuo CC, Saikku P. An epidemic of infections due to Chlamydia pneumoniae in military conscripts. Clin Infect Dis. 1993;17:420-425.
33. Linnanmäki E, Leinonen M, Mattila K, Nieminen MS, Valtonen V, Saikku P. Presence of Chlamydia pneumoniae specific antibodies in circulating immune complexes in coronary heart disease. Circulation. 1993;87:1130-1134.
34. Pesonen E. Coronary wall thickening in children: an analysis of the factors associated with the growth of arterial layers. Atherosclerosis. 1974;20:173-187.
35. Linnavuori K. History of recurrent mucocutaneous herpes correlates with relatively low interferon production by herpes simplex virus-exposed cultured monocytes. J Med Virol. 1988;25:61-68.
36. Saikku P, Leinonen M, Tenkanen L, Linnanmäki E, Ekman MR, Manninen V, Mänttäri M, Frick MH, Huttunen JK. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med. 1992;116:273-278.
37. Kuo C-C, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis. 1993;167:841-849.
38. Ramirez JA, Chlamydia pneumoniae/Atherosclerosis Study Group. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann Intern Med. 1996;125:979-982.
39. Ong G, Thomas BJ, Mansfield AO, Davidson BR, Taylor-Robinson D. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol. 1996;49: 102-106.
40. Blasi F, Denti F, Erba M, Cosentini R, Raccanelli R, Rinaldi A, Fagetti L, Esposito G, Ruberti U, Allegra L. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol. 1996;34:2766-2769.
41. Pasceri V, Cammarota G, Patti G, Cuoco L, Gasbarrini A, Grillo RL, Fedeli G, Gasbarrini G, Maseri A. Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation. 1998;97: 1675-1679.
42. Nieto FJ, Sorlie P, Comstock GW, Wu K, Adam E, Melnick JL, Szklo M. Cytomegalovirus infection, lipoprotein(a), and hypercoagulability: an atherogenic link? Arterioscler Thromb Vasc Biol 1997;17:1780-1785.
43. Blum A, Giladi M, Weinberg M, Kaplan G, Pasternack H, Laniado S, Miller H. High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis. Am J Cardiol. 1998;81:866-868.
44. Ridker PM, Hennekens CH, Stampfer MJ, Wang F. Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke. Circulation. 1998;98:2796-2799.
45. Das I. Raised C-reactive protein levels in serum. Clin Chim Acta. 1985; 153:9-13.
46. Kuller LH, Tracy RP, Shaten J, Meilahn EN. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study: multiple risk factor intervention trial. Am J Epidemiol. 1996;144: 537-547.
47. Ridker PM. Inflammation, infection, and cardiovascular risk: how good is the clinical evidence? Circulation 1998;97:1671-1674.